Tel Aviv – New York – Interview with Alpha Tau CEO following regulatory approval for Alpha DaRT in Japan
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study